HIGHLIGHTS
- who: Julia Degering from the (UNIVERSITY) have published the research: Tolerability, safety and survival in patients with severe pulmonary arterial hypertension treated with intravenous epoprostenol (Veletri, in the Journal: (JOURNAL)
- what: Survival was as expected in these prevalent severely impaired patients. u2020 Julia Degering and Benjamin Egenlauf equally contributed to this work Correspondence: Ekkehard Gru00fcnig Full list of author information is available at the end of the Article permits use sharing adaptation distribution and reproduction in any medium or format as long as you give appropriate credit to the original author(s) and the source . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.